This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
mtaschetta-millane Thu, 07/11/2024 - 10:53 July 11, 2024 — Heart Test Laboratories, Inc. Heartfailure (HF) is a growing worldwide public health issue affecting 64 million people annually 1 and is associated with high mortality, lower quality of life and reduced physical capacity while placing substantial costs on the healthcare system.
Background This review aimed to compare the relative effectiveness of different exercise-based cardiac rehabilitation (ExCR) delivery modes (centre-based, home-based, hybrid and technology-enabled ExCR) on key heartfailure (HF) outcomes: exercise capacity, health-related quality of life (HRQoL), HF-related hospitalisation and HF-related mortality.
12, 2024 Physicians have a new treatment option for many of the sickest pediatric patients with heartfailure andcardiogenic shock. and Impella CP enable heart recovery as part of the world's smallest heart pump platform. with SmartAssist tim.hodson Wed, 12/18/2024 - 14:06 Dec.
"Tricuspid regurgitation can put added strain on the heart and lead to other cardiovascular issues, which can significantly worsen a person's quality of life, but historically there have been few treatment options," said Lars Søndergaard , M.D.,
We now have one more technology, on the verge of approval by the FDA. Final message WiSE CRT uses some revolutionary technology and it is a welcome addition in few eligible patients. However, advanced heartfailure therapy never means it can be achieved only by state-of-the-art technology. Reference 1. 2024.2050 2.
There, he served as an investigator in many high-profile clinical trials, including several significant structural heart studies. Dr. Shreenivas is a frequent speaker at major scientific meetings and has been widely published in peer-reviewed journals across the structural heart, heartfailure, and coronary arenas.
Geisinger is at the forefront of research and technological advancements that allow for better patient outcomes and improvements in their quality of life.” Cardiac amyloidosis is caused by protein buildup between the muscle cells of the heart, increasing the thickness of the heart.
BACKGROUND:Despite advances in medical and cardiac resynchronization therapy (CRT), individuals with chronic congestive heartfailure (CHF) have persistent symptoms, including exercise intolerance. Circulation, Ahead of Print. Mean arterial pressure was significantly lower during diastolic walking (85±12 versus 98±20 mm Hg;P=0.007).CONCLUSIONS:In
Indeed, chronic inflammation and immune dysregulation play pivotal roles in most cardiovascular conditions, including arrhythmias, atherothrombosis, ischemic heart disease, heartfailure, and valve disease. Copyright 2025 Wolters Kluwer Health, Inc. All rights reserved.
The device is a patented 3-lead, 2-channel wireless continuous ECG wearable device that allows physicians the ability to address and assess sleep and heart health remotely. The achievement follows the recent announcement of Cor's capability to capture real-time, AI-enabled on-demand ejection fraction (EF). David's Medical Center.
The Need for Personalization in Cardiology Cardiovascular health is inherently complex, with conditions ranging from hypertension to heartfailure requiring specific treatment plans. Technological barriers , including outdated or incompatible systems. Regulatory issues that may limit how data can be shared between institutions.
CMS has reviewed the CardiAMP HeartFailure II Trial and approved the investigational product, related and routine items and services for purposes of Medicare coverage. The CardiAMP HeartFailure II Trial is FDA approved to enroll up to 250 patients at up to 40 clinical centers. said Peter Altman , PhD.,
million Department of Defense grant awarded to the Georgia Institute of Technology (Georgia Tech), Yaxin Wang, PhD (seated left), O.H. suffer from heartfailure , and there are approximately 400,000 heart-failure-related deaths in this country each year. Through a new four-year, $7.8
At present, the main methods to treat ischemic heart disease are drug therapy, intervention and operation. These methods only alleviate symptoms of heartfailure and myocardial ischemia and improve patients' quality of life by partially restoring myocardial reperfusion.
AI-enabled remote cardiac monitoring is is already revolutionizing how we detect, diagnose, mitigate and manage heart conditions. By enabling the decisive shift from a reactive to a proactive cardiology model, this technology doesnt just improve patient outcomes it is also helping keep cardiovascular care sustainable and affordable.
a commercial-stage medical device company, announced today the availability of additional data, including the publication of results of the post-market phase of the BeAT-HF trial in the European Journal of HeartFailure. The manuscript is available online at the European Journal of HeartFailure website.
The primary effectiveness endpoint was a composite of death, heart transplant/left ventricular assist device (LVAD) implantation, HF hospitalization, outpatient HF worsening, and quality of life. and worldwide," said Neal Eigler, M.D. , CEO of V-Wave. Canada, Israel, Australia and New Zealand. million people globally.
Food and Drug Administration (FDA) approval of its TriClip, a first-of-its-kind device to repair leaky tricuspid heart valve, for which more than 1.6 are affected by tricuspid regurgitation, 1 which can severely impact quality of life. Abbott has announced U.S million people in the U.S. are estimated to be affected. and Lynn C.
Image courtesy: Philips christine.book Wed, 06/12/2024 - 14:07 June 12, 2024 — Royal Philips has announced its next-generation AI-enabled cardiovascular ultrasound platform to help speed up cardiac ultrasound analysis with proven AI technology and reduce the burden on echocardiography labs.
Digital technologies may reveal it is even more common than the current analysis indicates. The study appears Sept. 11 in the Journal of the American College of Cardiology JACC. Marcus, MD, MAS, a cardiologist and electrophysiologist at UCSF Health.
milla1cf Thu, 03/28/2024 - 07:30 March 28, 2024 — Medtronic plc, a global leader in healthcare technology, announced that the United States Food and Drug Administration ( FDA ) has approved the Evolut FX+ transcatheter aortic valve replacement (TAVR) system for the treatment of symptomatic severe aortic stenosis.
Compared to their peers without the condition, people with atrial fibrillation are twice as likely to be admitted to hospital, five times more likely to have a stroke, three times more likely to develop heartfailure, and twice as likely to die prematurely.4 The risk of death is extremely low (0.05-0.1%).
Digital technologies may reveal it is even more common than the current analysis indicates. The study appears Sept. 11 in the Journal of the American College of Cardiology JACC. Marcus, MD, MAS, a cardiologist and electrophysiologist at UCSF Health.
The Role of Cardiologists Cardiologists are at the forefront of the battle against heart diseases. Their expertise covers a wide range of cardiovascular conditions, including coronary artery disease, heartfailure, arrhythmias, and congenital heart defects.
4 Keys To Partnering With Patients: The Cornerstone of Effective Cardiorenal Metabolic Management At the heart of any successful healthcare intervention lies the patient. Engaging individuals as active participants in their care plans can significantly enhance outcomes and improve overall quality of life.
The pandemic taught us that telehealth, virtual care, and innovative diagnostic technology enable providers and caregivers to expand capabilities, regardless of location. Specialists need to partner with local primary care clinicians – using technology to meet patients where they are – to reverse this reality.
Adult Cardiac Surgery Database Lead Author Title Publication Date Jacob Raphael Red Blood Cell Transfusion and Pulmonary Complications: The Society of Thoracic Surgeons Adult Cardiac Surgery Database Analysis The Annals of Thoracic Surgery January 2024 Joseph Sabik Multi-Arterial versus Single-Arterial Coronary Surgery: Ten Year Follow-up of One Million (..)
Linking guideline-directed medical therapy (GDMT) implementation and appropriate polypharmacy management in heartfailure (HF). Polypharmacy can represent a barrier to the proper implementation of life-prolonging GDMT for HF.
28, 2024 — Cardiawave SA, developer of Valvosoft Non-Invasive Ultrasound Therapy (NIUT) device for treating severe symptomatic calcific aortic stenosis (CAS), announced that the device met the primary endpoint in its pivotal study and improved or stabilized heartfailure symptoms for 80.5 tim.hodson Thu, 11/07/2024 - 10:19 Oct.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content